Veeral Desai, Chief Strategy & Development Officer at agilon health, inc. (AGL), sold 242,002 shares at $28.98 ($7.0M) on 2021-09-14, disclosed to the SEC on 2021-09-15.
Open-market sale of $7.0M AGL by Chief Strategy & Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.98 | 121,001 | $3.5M | 50.0% |
| 2 | $28.98 | 121,001 | $3.5M | 50.0% |
| Total | $28.98 avg | 242,002 | $7.0M | 100% |
| Filing → |
| AGL | SELL | 2023-03-27 | $4.1M | — | Filing → |
| AGL | SELL | 2023-03-17 | $1.6M | — | Filing → |
| AGL | SELL | 2022-07-25 | $2.2M | — | Filing → |